Adenomyosis. Endometriosis of uterus
Conditions
Interventions
Intervention 1: Intervention group: The Depakin oral tablets will be started at a dose of 500 mg twice a day from the 5th day of the menstrual cycle in the first week. The dosage will be increased to
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Having clinical symptoms of adenomyosis (chronic pelvic pain, Heavy Menorrhagia, abnormal uterine bleeding, acute Dysmenorrhea, Dyspareunia, enlargement of the uterus, tenderness of the uterus) Pelvic examination suggestive of Adenomyosis Transvaginal ultrasound diagnostic findings of Adenomyosis
Exclusion criteria
Exclusion criteria: Pregnancy, suspicion of pregnancy or planning to become pregnant Breastfeeding Hepatic, renal, heart and internal diseases Lack of patient collaboration or desire to performing the hysterectomy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Dysmenorrhea. Timepoint: At the beginning of the study (before the intervention) and 1, 2, 3, 4, 5 and 6 months after starting the intervention. Method of measurement: Visual Analogue Scale.;Uterine Size. Timepoint: At the beginning of the study (before the intervention) and 6 months after starting the intervention. Method of measurement: Ultrasound.;The statues of the palpable nodule in the vaginal examination. Timepoint: At the beginning of the study (before the intervention) and 1, 2, 3, 4, 5 and 6 months after starting the intervention. Method of measurement: Vaginal Examination. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr.Rosita Firoozian
Arash Women 's Hospital
Outcome results
None listed